CD4-IgG

DRUG6 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Genentech, Inc.

Conditions

HIV InfectionsImmune Thrombocytopenic Purpura ( ITP )Pregnancy

Phase 1

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns

CompletedNCT00000642

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Pregnancy

Target: 30Updated: 2005-06-24

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

CompletedNCT00000663

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Target: 18Updated: 2005-06-24

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex

CompletedNCT00000976

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Target: 40Updated: 2008-08-06

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex

CompletedNCT00000675

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Target: 60Updated: 2005-06-24

A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura

CompletedNCT00002250

Genentech, Inc.HIV Infections, Immune Thrombocytopenic Purpura ( ITP )

Updated: 2005-06-24

Unknown Phase

An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection

CompletedNCT00000647

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

End: 1994-12-31Target: 6Updated: 2021-10-27